Page last updated: 2024-10-31

nafronyl and Epilepsy

nafronyl has been researched along with Epilepsy in 1 studies

Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pechadre, JC1
Barrionuevo, G1
Gautron, M1

Other Studies

1 other study available for nafronyl and Epilepsy

ArticleYear
[Letter: Epileptic seizures after naftidrofuryl injection].
    La Nouvelle presse medicale, 1976, Feb-21, Volume: 5, Issue:8

    Topics: Animals; Brain; Carotid Arteries; Electroencephalography; Epilepsy; Furans; Haplorhini; Humans; Inje

1976